Neurology
On demand · Available until 30 Jun 2027
Journal CME 41.06: An Open-Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington’s Disease
A course in neurology by International Parkinson and Movement Disorder Society. See the official website for the programme and registration details.
